TABLE 5.
Levels of Ras Protein and AP-1 Transactivating Activity
| Clone | Vector | MGSA/GROβ | MGSA/GROγ | MGSA/GROα |
|---|---|---|---|---|
| Ras protein expression level (fold) | 1 | 4.15 ± 0.65 | 3.25 ± 0.05 | 7.00 ± 0.90 |
| Basal AP-1 transactivation (fold) | 1 | 1.12 ± 0.32 | 2.10 ± 0.18 | 3.16 ± 0.45 |
| Dominant-negative Ras inhibits AP-1 transactivation | 0.54 ± 0.10 | 0.48 ± 0.01 | 0.43 ± 0.12 |
The level of Ras protein and AP-1 transactivating activity were monitored by Western blot and by luciferase activity in the MGSA/GROα-, β-, and γ-expressing melan-a clones as described in Materials and Methods. The luciferase and β-Gal activities were measured 48 h after transfection. Transfection efficiency was normalized by comparing AP-1 luciferase activity to β-galactosidase activity. The data are reported as mean ± SEM fold induction (the relative luciferase activity of MGSA/GROα, β, γ divided by the relative luciferase activity of the vector) from three independent experiments. In experiments involving dominant-negative Ras transfection, the results are reported as mean fold inhibition ± SEM (the relative luciferase activity of dominant-negative form of M-Ras divided by the relative luciferase activity of pBK-CMV vector) from three independent experiments. Co-transfection of the dominant negative Ras expression construct with the AP-1 luciferase reporter construct resulted in a marked reduction in endogenous AP-1 reporter activity.